Business Wire (May 14, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
516 people get PKI articles and Market Currents by email alert.
Get email alerts on PKI »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 13, 2013)
-
-
-
-
-
-
-
-
PerkinElmer's 1Q Whiff: Time To Buy Or Stay Away?Tech Guru • Fri, Apr 26 -
Business Wire (Apr 25, 2013)
-
-
Business Wire (Apr 9, 2013)
-
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 4, 2013)
-
To learn more about Seeking Alpha Pro, click here.
-
PerkinElmer's 1Q Whiff: Time To Buy Or Stay Away?Tech Guru • Fri, Apr 26
-
PerkinElmer Beats on All FrontsZacks Investment Research • Fri, May 6, 2011 -
PerkinElmers: Firing on All CylindersRobert Freedland • Mon, Aug 9, 2010 -
Earnings Scorecard: PerkinElmerZacks Investment Research • Mon, May 24, 2010
-
Earnings Preview: PerkinElmerTheflyonthewall • Thu, Oct 29, 2009 -
PerkinElmer's Purchase of Chinese Diagnostic Firm Makes SenseChinaBio Today • Wed, Sep 9, 2009
-
Earnings Preview: PerkinElmerTheflyonthewall • Thu, Jul 30, 2009
-
Earnings Preview: PerkinElmerTheflyonthewall • Thu, Jan 29, 2009
-
Earnings Preview: PerkinElmerTheflyonthewall • Thu, Oct 23, 2008
-
Earnings Preview: PerkinElmerTheflyonthewall • Wed, Jul 23, 2008
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Earnings Analysis For Pall Corp.: Sustainable Returns Relative To PeersCapitalCube • Fri, Sep 14, 2012 -
Cepheid: Awesome Company, But OverpricedDave Westenberg • Fri, Aug 10, 2012
-
-
4 Stocks To Buy And Sell NowThe Oxen Group • Wed, Jun 20, 2012
-
-
-
PerkinElmer's CEO Discusses Q1 2012 Results - Earnings Call TranscriptThu, Apr 26, 2012
-
PerkinElmer, Inc. Q2 2010 Earnings Call TranscriptThu, Aug 5, 2010
-
PerkinElmer, Inc. F1Q10 (Qtr End 04/04/10) Earnings Call TranscriptFri, May 7, 2010
-
PerkinElmer, Inc. Q4 2009 Earnings Call TranscriptFri, Feb 5, 2010
-
Perkinelmer, Inc. Q3 2009 Earnings Call TranscriptThu, Oct 29, 2009
-
PerkinElmer Q2 2009 Earnings TranscriptFri, Jul 31, 2009
-
PerkinElmer, Inc. Q1 2009 Earnings Call TranscriptThu, Apr 30, 2009
-
PerkinElmer Inc. Q4 2008 Earnings Call TranscriptThu, Jan 29, 2009
-
PerkinElmer Inc. Q3 2008 Earnings Conference Call TranscriptFri, Oct 24, 2008
-
Business Wire (May 13, 2013)
-
at CNBC.com (Apr 30, 2013)
-
at MarketWatch.com (Apr 26, 2013)
-
at MarketWatch.com (Apr 26, 2013)
-
Business Wire (Apr 25, 2013)
-
at MarketWatch.com (Apr 15, 2013)
-
Business Wire (Apr 9, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 25, 2013)
-
Business Wire (Jan 7, 2013)
-
at CNBC.com (Jan 3, 2013)
-
Business Wire (Dec 19, 2012)
-
Business Wire (Nov 12, 2012)
-
at MarketWatch.com (Oct 26, 2012)
-
Business Wire (Oct 25, 2012)
-
Business Wire (Oct 24, 2012)
PKI vs. ETF Alternatives
Company Description
We are a leading provider of technology, services and solutions to the diagnostics, research, environmental, safety and security, industrial and laboratory services markets. Through our advanced technologies, applications, and services, we address critical issues that help to improve the health... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, May 10, 3:45 PM PerkinElmer (PKI +1.2%) introduces a new version of Lead Discovery for the Tibco Spotfire software platform, which, when combined with the Tibco Spotfire software's advanced data visualization and analysis capabilities, brings a new level of chemical intelligence to the informatics platform for advanced scientific discovery. The new version, called Lead Discovery 5.1, uses PKI's ChemDraw drawing tool to improve the capabilities of data analysis with new functionality built to assist chemists. Comment! [Healthcare, On the Move]
-
Friday, April 26, 1:03 PM
Midday top 10 gainers: LOGM +24%. LAS +17%. CTCT +16%. NR +15%. DQ +15%. WBSN +14%. QLIK +13%. CPGI +13%. SPWR +12%. CSIQ +12%.
Midday top 10 losers: DYAX -32%. HXM -23%. DLA -16%. IKAN -16%. KEG -15%. FALC -14%. COBR -13%. PKI -13%. XIDE -12%. MMSI -12%. Comment! [On the Move] - Friday, April 26, 11:48 AM ISI's Ross Muken downgrades PerkinElmer (PKI -11.7%) to Buy from Strong Buy after the company's Q1 miss. "This is a pretty terrible outcome from at least [an] earnings and operating income standpoint," Muken said on the call after asking management if they have "a hold" on where business is and what caused "pullbacks in demand." CEO Robert Friel cited a political shakeup for weakness in Japan and said he is still "fairly bearish on Europe." ISI's new price target: $36. (transcript) Comment! [On the Move]
-
Friday, April 26, 9:11 AM
Premarket gainers: LOGM +19%. AVNR +16%. SYNA +17%. QLIK +12%. CRIS +9%. DHI +7%. THRX +7%. MUX +7%. JCP +7%. CSTR +6%.
Losers: PKI -14%. SIMO -11%. BIDU -9%. KEG -8%. SDT -5%. Comment! [On the Move] -
Thursday, April 25, 5:55 PM
After-hours top gainers, as of 5:15 p.m.: SYNA +18%. LOGM +15%. QLIK +13%. AMKR +10%. INFA +9%.
After-hours top losers: PKI -14%. ECHO -8%. CDNS -7%. CLGX -7%. MCRS -7%. Comment! [On the Move] - Thursday, April 25, 5:10 PM More on PerkinElmer's (PKI) Q1: Shares grind 14% lower in late trading after earnings miss on the top and bottom line. Adjusted operating profit margins fall to 12.6% from 15.6% in Q1 2012. The company says it experienced "significant headwinds" in Europe and Japan. Adjusted operating income from the Environmental Health segment falls 31.5% Y/Y, while operating profit margins in the unit shed 160 basis points. PKI sees FY13 non-GAAP EPS of $2.00-2.10 — analysts expect $2.29. (PR) Comment! [Earnings, On the Move]
- Thursday, April 25, 4:34 PM PerkinElmer (PKI): Q1 EPS of $0.36 misses by $0.12. Revenue of $505.4M (-1% Y/Y) misses by $27.51M. Shares -11.6% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Thursday, April 25, 12:10 AM Notable earnings after Thursday’s close: AEM, ALTR, AMCC, AMKR, AMZN, BIDU, BJRI, BLDR, BMRN, CALX, CAMP, CB, CBG, CENX, CERN, CINF, CLWR, CRUS, CSTR, CTCT, DECK, DLB, ELY, EMN, EXPE, FII, FR, FSL, GERN, IGT, IM, INAP, INFA, KBR, KEG, KLAC, LEG, MCRS, MXIM, N, NR, NTGR, OLN, PFG, PKI, PMCS, QLIK, RMD, RRC, RSG, SBUX, SIMO, SPN, SWKS, SYNA, TCO, THRX, TLAB, UHS, VPRT, VRSN, WRE, WYNN Comment! [Earnings]
- Wednesday, April 24, 5:35 PM Notable earnings after Thursday’s close: AEM, ALTR, AMCC, AMKR, AMZN, BIDU, BJRI, BLDR, BMRN, CALX, CAMP, CB, CBG, CENX, CERN, CINF, CLWR, CRUS, CSTR, CTCT, DECK, DLB, ELY, EMN, EXPE, FII, FR, FSL, GERN, IGT, IM, INAP, INFA, KBR, KEG, KLAC, LEG, MCRS, MXIM, N, NR, NTGR, OLN, PFG, PKI, PMCS, QLIK, RMD, RRC, RSG, SBUX, SIMO, SPN, SWKS, SYNA, TCO, THRX, TLAB, UHS, VPRT, VRSN, WRE, WYNN Comment! [Earnings]
- Thursday, January 31, 4:56 PM More on PerkinElmer (PKI): Q4 EPS comes in line with estimates. Net losses narrowed on higher organic revenue plus an income-tax benefit. Human health segment revenue improved 6.5%. For FY13, the company forecast earnings of $2.24 to $2.32 a share, on organic revenue growth in the mid-single-digit range. Street expectations are for $2.32 per a share and growth of 4.8%, respectively. Comment! [Healthcare, Earnings]
- Thursday, January 31, 4:33 PM PerkinElmer (PKI): Q4 EPS of $0.65 in-line. (PR) Comment! [Earnings, Breaking News]
- Friday, January 25, 4:34 PM PerkinElmer, Inc. (PKI) declares $0.07/share quarterly dividend, in line with previous. Forward yield 0.79%. For shareholders of record Apr. 19. Payable May 10. Ex-div date Apr. 17. (PR) Comment! [Dividends]
- Monday, November 12, 2012, 4:28 PM PerkinElmer (PKI) says it's completed the acquisition of Shanghai Haoyuan Biotech, a China-based infectious disease diagnostics company, for $38M in cash plus future consideration based on the achievement of revenue-based targets. PKI says the deal should be immaterial to adjusted earnings for the remainder of 2012 and 2013 and accretive beginning in 2014. Comment! [Healthcare, Global & FX, M&A]
- Thursday, October 25, 2012, 4:50 PM More on Perkin Elmer (PKI): Q3 beats across the board on strong revenue growth out of its human-health focused segment. Net profit declined 19% however, due largely to lower contributions from businesses that the company has sold. For FY12, the company raises its per-share earnings estimate to $2.05 to $2.07, up from its prior estimate for $2 to $2.05, and reiterated its forecast for organic revenue growth. Comment! [Healthcare, Earnings]
- Thursday, October 25, 2012, 4:40 PM PerkinElmer (PKI): Q3 EPS of $0.45 beats by $0.01. Revenue of $509.6M (+13% Y/Y) beats by $4M. (PR) Comment! [Earnings, Tech]
- Wednesday, October 24, 2012, 6:43 PM PerkinElmer (PKI) declares $0.07/share quarterly dividend, in line with previous. Forward yield 0.99%. For shareholders of record Jan 18. Payable Feb 08. Ex-div date jan 16. (PR) Comment! [Dividends]
-
Alan Brochstein
Cramer discussed his latest break-up idea, $PKI, and it makes sense: http://seekingalpha.com/c/awlmv - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
Dividend Yields: The Dividend Guy's Portfolio With 8 Percent Payout + http://t.co/3GYfn6C + $HSE $POW $T $DGI.UN $ALA $AT $FTN $PKI $WRK.UN - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
Ex-Dividend Dates: Best Yields with Ex-Dividend Day January 17 - 23, 2011 +++ http://t.co/ssQYJkF +++ $HRL $PG $PKI $RBN $REXI $BCR $LEN - View all 0 replies
LATEST REPLIES